Women's Health News

RSS

Lapatinib plus trastuzumab extend lives of HER2-positive breast cancer patients

Lapatinib plus trastuzumab are significantly better than lapatinib alone in extending the lives of breast cancer patients whose tumors are HER2-positive, according to Kimberly Blackwell, M.D., associate professor of medicine at Duke University Medical Center.

12 Dec 2009

Results from clinical survey of Oncotype DX on patients with node-positive breast cancer announced

Genomic Health, Inc. today announced results from a clinical survey evaluating the impact of the Oncotype DX® Recurrence Score® result on physicians' adjuvant treatment recommendations for patients with node-positive, hormone receptor-positive breast cancer.

12 Dec 2009

Kaiser Permanente: Women of Chinese and Korean heritage may develop diabetes during pregnancy

More than 10 percent of women of Chinese and Korean heritage may be at risk for developing diabetes during pregnancy, according to a Kaiser Permanente study of 16,000 women in Hawaii that appears in the December issue of the Ethnicity and Disease journal.

11 Dec 2009

Anti-estrogens may reduce the risk of death from lung cancer, according to study results

Anti-estrogens as therapy for breast cancer may also reduce the risk of death from lung cancer, according to study results presented at the CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 9-13, 2009.

11 Dec 2009

African-American women in South Carolina more likely to have cervical cancer than white women

African-American women in South Carolina are 37 percent more likely to have cervical cancer than white women and have a death rate that is about 61 percent higher, according to a study by researchers at the University of South Carolina's Arnold School of Public Health.

11 Dec 2009

Proposed changes to breast cancer screening criticized

The Editor-in-Chief of Cancer Investigation and one of the country's most respected medical policy professors has written a new commentary which criticizes proposed changes to breast cancer screening.

11 Dec 2009

Store brand infant formulas nutritionally equivalent to name-brand products

On October 1, changes were made to the federal WIC program that provides nutritional support to low-income women, infants and children. The goal of the new food package is to encourage breastfeeding because mother's milk is best for babies. Mothers who breastfeed will no longer receive any infant formula under the new program. Mothers who choose to formula feed may receive up to 26% fewer infant formula vouchers than were afforded in previous years.

11 Dec 2009

California's EWC program: Cuts alarm breast cancer survivors and advocates

Breast cancer survivors and advocates from all seven California Affiliates of Susan G. Komen for the Cure® signaled their alarm today at the recently announced cuts to California's Every Woman Counts program, which would effectively shut the doors to breast cancer screening services for 1.2 million low-income and uninsured women for the first six months of 2010.

11 Dec 2009

Chemotherapy improves overall survival in postmenopausal breast cancer patients

Chemotherapy generally improves survival in postmenopausal breast cancer patients, according to a landmark study led by Dr. Kathy Albain of Loyola University Health System.

11 Dec 2009

Positive results from Genomic Health's Oncotype DX study in breast cancer patients with node-positive disease

Genomic Health, Inc. today announced that The Lancet Oncology published positive results from a study of Oncotype DX(®) in postmenopausal women with node-positive, estrogen receptor-positive breast cancer conducted by the Southwest Oncology Group (SWOG), a National Cancer Institute-supported clinical trials cooperative group.

11 Dec 2009

Women with high BMI are at increased risk of dying from breast cancer

Breast cancer patients with a high body mass index (BMI) have a poorer cancer prognosis later in life. Specifically, their treatment effect does not last as long and their risk of death increases.

11 Dec 2009

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

AstraZeneca (NYSE: AZN) today announced that data from a Phase III study of postmenopausal women with hormone receptor-positive advanced breast cancer presented at the San Antonio Breast Cancer Symposium (Abstract 25) showed treatment with fulvestrant (FASLODEX) 500 mg reduced the risk of disease progression (assessed as time to progression (TTP)) by 20%

11 Dec 2009

Soyfood consumption linked to decreased risk of breast cancer, finds study

A major new study published in the Journal of the American Medical Association (JAMA) finds that women with breast cancer would be well-served by including soyfoods in their daily diet. Soyfood consumption was significantly linked to a decreased risk of death and cancer recurrence among the breast cancer patients in this study.

11 Dec 2009

Moderate consumption of alcoholic beverages increases the risk of breast cancer recurrence

Moderate consumption of alcoholic beverages (at least three to four drinks per week, no matter the type of alcohol) is associated with a 30 percent increased risk of breast cancer recurrence, according to a new Kaiser Permanente study. Post-menopausal or overweight women may be most susceptible to the effects of alcohol on recurrence, according to the researchers.

10 Dec 2009

YM BioSciences announces results of collaborative antibody development program

YM BioSciences Inc., today announced the first results of a collaborative program between YM and the National Research Council of Canada's Biotechnology Research Institute (NRC-BRI). Utilizing YM's IntelliMab(TM) technology, the program is designed to generate novel antibodies that target cell surface receptors associated with cancer, uniquely optimized to produce efficacy with reduced toxicities.

10 Dec 2009

U.S. bishops: Senate vote to table Nelson-Hatch-Casey amendment, a serious blow to genuine health care reform

"The Senate vote to table the Nelson-Hatch-Casey amendment is a grave mistake and a serious blow to genuine health care reform," said Cardinal Francis George, President of the United States Conference of Catholic Bishops.

10 Dec 2009

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from the Tulip PETAL Study (703 Study), its fifth Phase 2 clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.

10 Dec 2009

Arrayit Diagnostics signs exclusive License Agreement with Wayne State University

Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today announced that it has signed an exclusive License Agreement with Wayne State University to key intellectual property covering discoveries of biomarkers of ovarian cancer.

10 Dec 2009

Roche to present data on its Herceptin, Avastin and T-DM1 studies at CTRC-AACR Symposium

Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.

9 Dec 2009

Senate rejects abortion amendment, sparking new fight

The Hill: "The Senate voted against strengthening restrictions for federal funding of abortion Tuesday evening, a development that could imperil Democrats' efforts to pass an underlying healthcare reform bill. Sen. Ben Nelson (D-Neb.), who offered the amendment, had indicated that he could support a Republican filibuster of the healthcare reform bill if the abortion language were not added to it."

9 Dec 2009

Women's Health News

Lapatinib plus trastuzumab extend lives of HER2-positive breast cancer patients

Results from clinical survey of Oncotype DX on patients with node-positive breast cancer announced

Kaiser Permanente: Women of Chinese and Korean heritage may develop diabetes during pregnancy

Anti-estrogens may reduce the risk of death from lung cancer, according to study results

African-American women in South Carolina more likely to have cervical cancer than white women

Proposed changes to breast cancer screening criticized

Store brand infant formulas nutritionally equivalent to name-brand products

California's EWC program: Cuts alarm breast cancer survivors and advocates

Chemotherapy improves overall survival in postmenopausal breast cancer patients

Positive results from Genomic Health's Oncotype DX study in breast cancer patients with node-positive disease

Women with high BMI are at increased risk of dying from breast cancer

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

Soyfood consumption linked to decreased risk of breast cancer, finds study

Moderate consumption of alcoholic beverages increases the risk of breast cancer recurrence

YM BioSciences announces results of collaborative antibody development program

U.S. bishops: Senate vote to table Nelson-Hatch-Casey amendment, a serious blow to genuine health care reform

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

Arrayit Diagnostics signs exclusive License Agreement with Wayne State University

Roche to present data on its Herceptin, Avastin and T-DM1 studies at CTRC-AACR Symposium

Senate rejects abortion amendment, sparking new fight

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News